Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network StudyYavuz Anacak, Mahmut Özsahin, Robert C. Miller et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 68
2522Yavuz Anacak, Nuran Beşe, Robert F. Miller et al.|International Journal of Radiation Oncology*Biology*Physics|2006Cited by 2
First-line (1L) trastuzumab deruxtecan (T-DXd)–based regimens in advanced HER2-expressing gastric cancer (GC), gastroesophageal junction adenocarcinoma (GEJA), or esophageal adenocarcinoma (EA): Safety results from DESTINY-Gastric03 (DG-03) Part 2 arms D and F, and Part 4.Yelena Y. Janjigian, J I Lee, Aitana Calvo Ferrándiz et al.|Journal of Clinical Oncology|2026Cited by 0